ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2175

Pediatric Rheumatology Clinic Referral Patterns at a Large Midwestern Center

Emily Fox1, Stephanie Quinn1, Ashley Lytch1, Angie Williams1, Julia Harris2 and Ashley Cooper3, 1Children's Mercy Hospital, Kansas City, MO, 2Children's Mercy Kansas City, Overland Park, KS, 3Children's Mercy Kansas City, Kansas City, MO

Meeting: ACR Convergence 2024

Keywords: Access to care, quality of care, Work Force

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Pediatric Rheumatology – Clinical Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Pediatric rheumatologists are facing a shortfall of providers and in multiple states, patients do not have readily accessible care for rheumatologic issues.  Our clinic noticed an increase in pediatric rheumatology referrals over the past two years with subsequent increase in wait times to be seen in clinic.  We sought to evaluate our referrals to ensure that referrals were appropriate to be seen in the rheumatology clinic or be directed to another specialty, escalate referrals for certain diagnoses that required immediate care, and to ensure that we had adequate records prior to clinic appointments to aid in patient care and patient satisfaction.

Methods: Our team centralized all referrals to a database where referrals were reviewed by a pediatric rheumatologist from March 2023 to March 2024. If records were not sent with the referral, the referring provider was contacted for pertinent records. The referral was then assessed for appropriateness for the rheumatology clinic as well as the timeframe that the patient should be seen. Patients felt to have potential diagnoses concerning for the following were escalated with clinic staff scheduling these patients with the goal of being seen in the pediatric rheumatology in one week: systemic lupus erythematosus, juvenile dermatomyositis, systemic juvenile idiopathic arthritis, systemic vasculitis, and chronic recurrent multifocal osteomyelitis.  If the referral was felt appropriate and did not need to be escalated, the referral was sent to our contact center to schedule first available.

Results: During this one-year time frame, we received 1,642 referrals to the pediatric rheumatology clinic with 1092 (67%) being female. Of those, 86 (5.2%) were felt to be inappropriate for the rheumatology clinic.  Our institution was unable to reach 229 (13.9%) families to schedule their appointments and of those scheduled, 70 (4.3%) did not keep their appointment and 13 (0.8%) had yet to have their appointment in clinic.  Of the 1,238 patients seen during that time, only 215 patients (17%) were diagnosed with a rheumatic condition (Table 1) with 69 (5.6%) patients being monitored at future appointments for evolution of their symptoms.  Most patients that were not felt to have a rheumatologic diagnosis were diagnosed with amplified pain, hypermobility/Ehlers-Danlos syndrome, combination of amplified pain and hypermobility, or a positive antinuclear antibody. Wait times for clinic decreased from the beginning of March 2023 where 25.6% of patients were seen within 14 days to 53.7% of patients being seen within 14 days by the first week of April 2024.

Conclusion: To streamline our referral process to improve access, schedule patients with critical diagnoses in clinic in a timely manner, as well as to ensure that patients seen in clinic were appropriate for rheumatology, we evaluated our referral pattern for a 12-month time span.  Most referrals seen in the clinic were diagnosed with a non-rheumatic condition with only 17% of patients felt to have a rheumatologic diagnosis.  Future work should include additional education for referring practitioners including appropriate lab testing and clinic referrals to reduce the burden for a small work force and save healthcare dollars.

Supporting image 1

Table 1: Rheumatologic Diagnoses Made Between March 2023-March 2024


Disclosures: E. Fox: None; S. Quinn: None; A. Lytch: None; A. Williams: None; J. Harris: None; A. Cooper: None.

To cite this abstract in AMA style:

Fox E, Quinn S, Lytch A, Williams A, Harris J, Cooper A. Pediatric Rheumatology Clinic Referral Patterns at a Large Midwestern Center [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/pediatric-rheumatology-clinic-referral-patterns-at-a-large-midwestern-center/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pediatric-rheumatology-clinic-referral-patterns-at-a-large-midwestern-center/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology